Rossari Biotech [ROSSARI] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison
Rossari Biotech
NSE
Loading...
Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Rossari Biotech wins in 12 metrics, Grauer & Weil wins in 8 metrics, with 0 ties. Rossari Biotech appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Rossari Biotech | Grauer & Weil | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.15 | 27.61 | Rossari Biotech |
| Price-to-Book Ratio | 2.98 | 4.62 | Rossari Biotech |
| Debt-to-Equity Ratio | 18.39 | 1.26 | Grauer & Weil |
| PEG Ratio | 19.00 | 38.47 | Rossari Biotech |
| EV/EBITDA | 14.77 | 20.33 | Rossari Biotech |
| Profit Margin (TTM) | 6.33% | 13.85% | Grauer & Weil |
| Operating Margin (TTM) | 9.22% | 7.46% | Rossari Biotech |
| EBITDA Margin (TTM) | 9.22% | 7.46% | Rossari Biotech |
| Return on Equity | 11.50% | 18.02% | Grauer & Weil |
| Return on Assets (TTM) | 7.19% | 8.70% | Grauer & Weil |
| Free Cash Flow (TTM) | $-210.69M | $999.80M | Grauer & Weil |
| Dividend Yield | 6.54% | 1.05% | Rossari Biotech |
| 1-Year Return | -30.03% | 1.69% | Grauer & Weil |
| Price-to-Sales Ratio (TTM) | 1.65 | 3.83 | Rossari Biotech |
| Enterprise Value | $36.88B | $38.18B | Grauer & Weil |
| EV/Revenue Ratio | 1.73 | 3.36 | Rossari Biotech |
| Gross Profit Margin (TTM) | 31.70% | 41.05% | Grauer & Weil |
| Revenue per Share (TTM) | $386 | $25 | Rossari Biotech |
| Earnings per Share (Diluted) | $24.37 | $3.47 | Rossari Biotech |
| Beta (Stock Volatility) | 0.27 | 0.28 | Rossari Biotech |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Rossari Biotech vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Rossari Biotech | -0.80% | -8.85% | -8.83% | -7.29% | -5.32% | -19.77% |
| Grauer & Weil | 0.05% | 1.00% | -8.63% | 14.99% | 3.51% | -8.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Rossari Biotech | -30.03% | -31.89% | -19.93% | -12.86% | -12.86% | -12.86% |
| Grauer & Weil | 1.69% | 42.58% | 122.46% | 397.91% | 980.68% | 747.59% |
Performance & Financial Health Analysis: Rossari Biotech vs Grauer & Weil
| Metric | ROSSARI | GRAUWEIL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹35.28B | ₹43.44B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 57,384 | 121,169 |
| 90 Day Avg. Volume | 123,891 | 162,991 |
| Last Close | ₹627.05 | ₹92.75 |
| 52 Week Range | ₹569.00 - ₹972.70 | ₹78.00 - ₹120.00 |
| % from 52W High | -35.54% | -22.71% |
| All-Time High | ₹1,619.00 (Oct 11, 2021) | ₹204.80 (Feb 26, 2024) |
| % from All-Time High | -61.27% | -54.71% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.02% |
| Quarterly Earnings Growth | -0.04% | -0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.14% |
| Operating Margin (TTM) | 0.09% | 0.07% |
| Return on Equity (TTM) | 0.12% | 0.18% |
| Debt to Equity (MRQ) | 18.39 | 1.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹214.12 | ₹20.72 |
| Cash per Share (MRQ) | ₹21.20 | ₹11.87 |
| Operating Cash Flow (TTM) | ₹440.09M | ₹1.44B |
| Levered Free Cash Flow (TTM) | ₹1.36B | ₹927.08M |
| Dividends | ||
| Last 12-Month Dividend Yield | 6.54% | 1.05% |
| Last 12-Month Dividend | ₹43.78 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Rossari Biotech vs Grauer & Weil
| Metric | ROSSARI | GRAUWEIL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.15 | 27.61 |
| Forward P/E | 19.00 | 38.47 |
| PEG Ratio | 19.00 | 38.47 |
| Price to Sales (TTM) | 1.65 | 3.83 |
| Price to Book (MRQ) | 2.98 | 4.62 |
| Market Capitalization | ||
| Market Capitalization | ₹35.28B | ₹43.44B |
| Enterprise Value | ₹36.88B | ₹38.18B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.73 | 3.36 |
| Enterprise to EBITDA | 14.77 | 20.33 |
| Risk & Other Metrics | ||
| Beta | 0.27 | 0.28 |
| Book Value per Share (MRQ) | ₹214.12 | ₹20.72 |
Financial Statements Comparison: Rossari Biotech vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ROSSARI | GRAUWEIL |
|---|---|---|
| Revenue/Sales | ₹5.44B | ₹3.40B |
| Cost of Goods Sold | ₹3.71B | ₹2.00B |
| Gross Profit | ₹1.72B | ₹1.40B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹501.06M | ₹237.20M |
| EBITDA | ₹695.76M | ₹417.40M |
| Pre-Tax Income | ₹460.99M | ₹343.50M |
| Income Tax | ₹125.03M | ₹86.10M |
| Net Income (Profit) | ₹335.96M | ₹257.40M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ROSSARI | GRAUWEIL |
|---|---|---|
| Cash & Equivalents | ₹442.02M | ₹1.08B |
| Total Current Assets | ₹10.42B | ₹9.36B |
| Total Current Liabilities | ₹5.37B | ₹2.97B |
| Long-Term Debt | ₹1.22B | ₹37.30M |
| Total Shareholders Equity | ₹11.85B | ₹9.39B |
| Retained Earnings | ₹6.97B | N/A |
| Property, Plant & Equipment | ₹0 | ₹2.47B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ROSSARI | GRAUWEIL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ROSSARI | GRAUWEIL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 57,384 | 121,169 |
| Average Daily Volume (90 Day) | 123,891 | 162,991 |
| Shares Outstanding | 55.36M | 453.41M |
| Float Shares | 16.51M | 127.47M |
| % Held by Insiders | 0.68% | 0.72% |
| % Held by Institutions | 0.20% | 0.00% |
Dividend Analysis & Yield Comparison: Rossari Biotech vs Grauer & Weil
| Metric | ROSSARI | GRAUWEIL |
|---|---|---|
| Last 12-Month Dividend | ₹43.78 | ₹1.00 |
| Last 12-Month Dividend Yield | 6.54% | 1.05% |
| 3-Year Avg Annual Dividend | ₹14.93 | ₹0.58 |
| 3-Year Avg Dividend Yield | 1.66% | 0.45% |
| 3-Year Total Dividends | ₹44.78 | ₹1.73 |
| Ex-Dividend Date | Jun 20, 2025 | Aug 06, 2025 |